These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8732945)

  • 1. Phenolphthalein highlights NTP bioassay review.
    Environ Health Perspect; 1996 Apr; 104(4):377-8. PubMed ID: 8732945
    [No Abstract]   [Full Text] [Related]  

  • 2. Fear of phenolphthalein?
    Environ Health Perspect; 1996 Mar; 104(3):250. PubMed ID: 8919757
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems.
    Dunnick JK; Hailey JR
    Cancer Res; 1996 Nov; 56(21):4922-6. PubMed ID: 8895745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice.
    Dunnick JK; Hardisty JF; Herbert RA; Seely JC; Furedi-Machacek EM; Foley JF; Lacks GD; Stasiewicz S; French JE
    Toxicol Pathol; 1997; 25(6):533-40. PubMed ID: 9437796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenolphthalein metabolite inhibits catechol-O-methyltransferase-mediated metabolism of catechol estrogens: a possible mechanism for carcinogenicity.
    Garner CE; Matthews HB; Burka LT
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):124-31. PubMed ID: 10637136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of susceptibility of heterozygous p53-knockout CBA and CIEA mice to phenolphthalein in a 6-month carcinogenicity study.
    Okamura M; Kashida Y; Watanabe T; Yasuhara K; Onodera H; Hirose M; Usui T; Tamaoki N; Mitsumori K
    Toxicology; 2003 Mar; 185(1-2):17-22. PubMed ID: 12505441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatitis medicamentosa (phenolphthalein) followed by pigmentary changes.
    VERO F
    Arch Derm Syphilol; 1949 Sep; 60(3):449. PubMed ID: 18147167
    [No Abstract]   [Full Text] [Related]  

  • 9. [On a case of erythrodermic rash generalized by phenolphthalein].
    MARZOCCHI L
    Dermosifilografo (Torino); 1948; 23(1):33-5. PubMed ID: 18912496
    [No Abstract]   [Full Text] [Related]  

  • 10. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fixed eruption by phenophthalene].
    THULLIEZ A
    Arch Belg Dermatol Syphiligr; 1949 Sep; 5(3):191. PubMed ID: 18148614
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenolphthalein.
    Rep Carcinog; 2004; 11():III214-6. PubMed ID: 21089944
    [No Abstract]   [Full Text] [Related]  

  • 13. Reproductive toxicology. Phenolphthalein.
    Environ Health Perspect; 1997 Feb; 105 Suppl 1(Suppl 1):335-6. PubMed ID: 9114350
    [No Abstract]   [Full Text] [Related]  

  • 14. NTP announces bioassay results.
    Environ Health Perspect; 1995 Feb; 103(2):139. PubMed ID: 7737058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenesis of phenophthalein-exanthema].
    EHRENGUT W
    Arch Kinderheilkd; 1952; 145(2):166-75. PubMed ID: 13017583
    [No Abstract]   [Full Text] [Related]  

  • 16. New NTP bioassay results.
    Environ Health Perspect; 1997 Mar; 105(3):282. PubMed ID: 9171987
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution of the uses of rats and mice for assessing carcinogenic risk from chemicals in humans.
    Ward JM
    Asian Pac J Cancer Prev; 2010; 11(1):18. PubMed ID: 20593921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and disposition of phenolphthalein in male and female F344 rats and B6C3F1 mice.
    Griffin RJ; Godfrey VB; Burka LT
    Toxicol Sci; 1998 Apr; 42(2):73-81. PubMed ID: 9579019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expectations for transgenic rodent cancer bioassay models.
    Ashby J
    Toxicol Pathol; 2001; 29 Suppl():177-82. PubMed ID: 11695555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative results of 327 chemical carcinogenicity studies.
    Haseman JK; Huff JE; Zeiger E; McConnell EE
    Environ Health Perspect; 1987 Oct; 74():229-35. PubMed ID: 3691430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.